| PERIOD ENDING | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | 31-Jul-08 | | Total Revenue | 54,891 | 59,180 | 64,450 | 65,242 | | Cost of Revenue | 25,209 | 29,684 | 29,885 | 29,618 | | | Gross Profit | 29,682 | 29,496 | 34,565 | 35,624 | | | Operating Expenses | | Research Development | 15,066 | 15,459 | 16,553 | 17,305 | | Selling General and Administrative | 18,919 | 19,589 | 19,230 | 15,681 | | Non Recurring |
-
|
-
| (87,811) |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (4,303) | (5,552) | 86,593 | 2,638 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 190 | 423 | 17,213 | 421 | | Earnings Before Interest And Taxes | (4,113) | (5,129) | 103,806 | 3,059 | | Interest Expense |
-
| 278 | 94 | 94 | | Income Before Tax | (4,113) | (5,407) | 103,712 | 2,965 | | Income Tax Expense | 16 | (1,840) | 3,132 | 23 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,129) | (3,567) | 100,580 | 2,942 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,129) | (3,567) | 100,580 | 2,942 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,129) | ($3,567) | $100,580 | $2,942 |
|
0.45% Nasdaq 
0.20%
Income Statement
